ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s | |
| Publication date | November 18, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |